A2780 Cell Line
- Datasheet
- References (12)
- Inventor Info
Info
| Catalogue Number | 152706 |
| Host | Human |
| Tissue | Ovary |
| Disease Keywords | Ovarian cancer cell line |
| Model | Tumour line |
| Relevance | The A2780 human ovarian cancer cell line was established from tumour tissue from an untreated patient. Cells grow as a monolayer and in suspension in spinner cultures. A2780 is the parent line to the cisplatin resistant cell line A2780 cis (catalogue no. 152708) and the adriamycin resistant cell line A2780 ADR (catalogue no. 152707). |
| Production Details | Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 3-6x10,000cells/cm² using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37°C. |
| Conditional | No |
| Research Area | Cancer, Drug Discovery & Development |
| Growth/Phenotype Keywords | Adherent |
| Recommended Growing Conditions | RPMI 1640 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS). |
| Notes |
STR-PCR Data: Amelogenin: X CSF1PO: 10,11 D13S317: 12,13 D16S539: 11,13 D5S818: 11,12 D7S820: 10 THO1: 6 TPOX: 8,10 vWA: 15,16 |
| Cellosaurus ID | CVCL_0134 |
References: 12 entries
Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.
Europe PMC ID: 24804215
Januchowski et al. 2014. Biomed Res Int. 2014:365867. PMID: 24804215.
Han et al. 2013. Oncol Lett. 6(5):1295-1298. PMID: 24179511.
A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties.
Europe PMC ID: 24179511
Barretina et al. 2012. Nature. 483(7391):603-7. PMID: 22460905.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Europe PMC ID: 22460905
Yu et al. 2000. Int J Oncol. 16(3):555-60. PMID: 10675489.
Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.
Europe PMC ID: 10675489
Henkels et al. 1997. Cancer Res. 57(20):4488-92. PMID: 9377558.
Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines.
Europe PMC ID: 9377558
Parker et al. 1991. J Clin Invest. 87(3):772-7. PMID: 1999494.
Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.
Europe PMC ID: 1999494
Add a reference
References: 12 entries
Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.
Januchowski et al. 2014. Biomed Res Int. 2014:365867. PMID: 24804215.
Han et al. 2013. Oncol Lett. 6(5):1295-1298. PMID: 24179511.
A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties.
Barretina et al. 2012. Nature. 483(7391):603-7. PMID: 22460905.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Yu et al. 2000. Int J Oncol. 16(3):555-60. PMID: 10675489.
Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.
Henkels et al. 1997. Cancer Res. 57(20):4488-92. PMID: 9377558.
Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines.
Parker et al. 1991. J Clin Invest. 87(3):772-7. PMID: 1999494.
Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.
Add a reference
